150
Participants
Start Date
June 30, 2009
Primary Completion Date
October 31, 2010
Study Completion Date
October 31, 2010
Meningococcal (Groups A, C, Y and W-135) Conjugate
2 x 0.5 mL dose
Meningococcal polysaccharide A, C, Y and W135 and Menveo
1 x 0.5 mL dose of ACWY Vax, 1 x 0.5 mL dose of Menveo
University of Oxford, Centre for Clinical Vaccinology and Tropical Medicine, Oxford
Collaborators (1)
Novartis Vaccines
INDUSTRY
University of Oxford
OTHER